| 1 | Abdominal Neoplasms | 42.9% |
| 2 | Head and Neck Neoplasms | 42.9% |
| 3 | Soft Tissue Neoplasms | 42.9% |
| 4 | Retroperitoneal Neoplasms | 31% |
| 5 | Digestive System Neoplasms | 30% |
| 6 | Endocrine Gland Neoplasms | 30% |
| 7 | Eye Neoplasms | 30% |
| 8 | Nervous System Neoplasms | 30% |
| 9 | Bone neoplasms | 28.6% |
| 10 | Skin Neoplasms | 28.6% |
| 11 | Hematologic Neoplasms | 28.6% |
| 12 | Splenic Neoplasms | 27.9% |
| 13 | Acanthoma | 25.8% |
| 14 | Parathyroid Neoplasms | 25% |
| 15 | Peritoneal Neoplasms | 25% |
| 16 | Thyroid Neoplasm | 25% |
| 17 | Thyroid carcinoma | 25% |
| 18 | Hamartoma | 23.1% |
| 19 | Neoplasms, Hormone-Dependent | 23.1% |
| 20 | Neoplasms, Multiple Primary | 23.1% |
| 21 | Paraneoplastic Syndromes | 23.1% |
| 22 | Precancerous Conditions | 23.1% |
| 23 | Neoplasms, Second Primary | 23.1% |
| 24 | Paraneoplastic Encephalomyelitis | 22.8% |
| 25 | Mammary Neoplasms, Experimental | 22.2% |
| 26 | Mouth Neoplasms | 20.9% |
| 27 | Pancreatic Neoplasm | 20.9% |
| 28 | Central Nervous System Neoplasms | 20.9% |
| 29 | Vascular Neoplasms | 20.9% |
| 30 | Genital Neoplasms, Female | 20.5% |
| 31 | Breast Neoplasms, Male | 20.2% |
| 32 | Triple Negative Breast Neoplasms | 20.2% |
| 33 | Thyroid Nodule | 20% |
| 34 | Multiple Endocrine Neoplasia | 19.8% |
| 35 | Esophageal Neoplasms | 18.4% |
| 36 | Carcinoma, Lobular | 18.2% |
| 37 | Meningioma | 16.9% |
| 38 | Meningeal Neoplasms | 16.9% |
| 39 | Testicular Neoplasms | 15.9% |
| 40 | Carcinoma, Pancreatic Ductal | 15.9% |
| 41 | Adrenal Gland Neoplasms | 15.8% |
| 42 | Gastrointestinal Neoplasms | 15.8% |
| 43 | Genital Neoplasms, Male | 15.8% |
| 44 | Liver neoplasms | 15.8% |
| 45 | Uveal Neoplasms | 15.8% |
| 46 | Urologic Neoplasms | 15.5% |
| 47 | Sebaceous Gland Neoplasms | 15.3% |
| 48 | Spinal Neoplasms | 15.3% |
| 49 | Bone Marrow Neoplasms | 15.3% |
| 50 | Cyst | 15% |
| 51 | Multiple Endocrine Neoplasia Type 1 | 15% |
| 52 | Neoplastic Processes | 15% |
| 53 | Neoplastic Syndromes, Hereditary | 15% |
| 54 | Pregnancy Complications, Neoplastic | 15% |
| 55 | Carcinoma, Ehrlich Tumor | 14.9% |
| 56 | Dermoid Cyst | 14.9% |
| 57 | Carcinoma, Lewis Lung | 14.9% |
| 58 | Meningeal Carcinomatosis | 14.9% |
| 59 | Carcinoma 256, Walker | 14.8% |
| 60 | Neoplasms, Experimental | 14.6% |
| 61 | insulinoma | 14.6% |
| 62 | Gastrinoma | 14.5% |
| 63 | Glucagonoma | 14.5% |
| 64 | Vipoma | 14.3% |
| 65 | Erythroplasia | 14.3% |
| 66 | Follicular cyst | 14.3% |
| 67 | leukemia | 14.3% |
| 68 | Mucocele | 14.3% |
| 69 | Neoplasms, Germ Cell and Embryonal | 14.3% |
| 70 | Neoplasms, Glandular and Epithelial | 14.3% |
| 71 | Pilonidal Cyst | 14.3% |
| 72 | Thyroglossal Cyst | 14.3% |
| 73 | Synovial Cyst | 14.3% |
| 74 | Germ Cell Cancer | 14.3% |
| 75 | Aberrant Crypt Foci | 14.3% |
| 76 | Leukoplakia, Oral | 14.1% |
| 77 | Paraneoplastic Cerebellar Degeneration | 14% |
| 78 | Neuroectodermal Tumors | 13.6% |
| 79 | Acoustic Neuroma | 13.5% |
| 80 | Palatal Neoplasms | 13.4% |
| 81 | Hepatocellular Adenoma | 13.3% |
| 82 | Neoplasms, Neuroepithelial | 13.3% |
| 83 | Gliomatosis cerebri | 13.3% |
| 84 | Ear Neoplasms | 13% |
| 85 | Eyelid Neoplasms | 13% |
| 86 | Liver Neoplasms, Experimental | 12.9% |
| 87 | Nose Neoplasms | 12.9% |
| 88 | Brain Neoplasms | 12.6% |
| 89 | Salivary Gland Neoplasms | 12.6% |
| 90 | Spinal Cord Neoplasms | 12.6% |
| 91 | Tongue Neoplasms | 12.6% |
| 92 | Tracheal Neoplasms | 12.4% |
| 93 | melanoma | 12.4% |
| 94 | Uterine Neoplasms | 12.4% |
| 95 | Vaginal Neoplasms | 12.4% |
| 96 | Vulvar Neoplasms | 12.4% |
| 97 | Uterine Cancer | 12.4% |
| 98 | Leydig Cell Tumor | 12.4% |
| 99 | Carcinosarcoma | 12.4% |
| 100 | Hemangiosarcoma | 12.4% |
| 101 | Leukemia L1210 | 12.4% |
| 102 | Leukemia P388 | 12.4% |
| 103 | lymphangiosarcoma | 12.4% |
| 104 | Fallopian Tube Neoplasms | 12.3% |
| 105 | Trophoblastic Neoplasms | 12.1% |
| 106 | Retinoblastoma | 12% |
| 107 | Leukemia, Experimental | 12% |
| 108 | Medulloblastoma | 11.9% |
| 109 | Melanoma, Experimental | 11.8% |
| 110 | Sarcoma 180 | 11.7% |
| 111 | Limbic Encephalitis | 11.6% |
| 112 | Optic Nerve Glioma | 11.5% |
| 113 | Adenoma, Acidophil | 11.5% |
| 114 | Ganglioneuroma | 11.5% |
| 115 | Glioma | 11.5% |
| 116 | Malignant Glioma | 11.5% |
| 117 | Pituitary Adenoma | 11.2% |
| 118 | Pituitary Neoplasms | 11.2% |
| 119 | Basal cell carcinoma | 11.1% |
| 120 | Carcinoma, Papillary | 11.1% |
| 121 | Squamous cell carcinoma | 11.1% |
| 122 | Chondrosarcoma | 11.1% |
| 123 | Craniopharyngioma | 11.1% |
| 124 | Cystadenoma | 11.1% |
| 125 | leiomyosarcoma | 11.1% |
| 126 | liposarcoma | 11.1% |
| 127 | Mesothelioma | 11.1% |
| 128 | Supratentorial Neoplasms | 11.1% |
| 129 | synovial sarcoma | 11.1% |
| 130 | Neuroectodermal Tumor, Melanotic | 11.1% |
| 131 | Angiomyolipoma | 11.1% |
| 132 | Clear Cell Sarcoma of Soft Tissue | 11.1% |
| 133 | Alveolar Soft Part Sarcoma | 11.1% |
| 134 | Neuroendocrine Tumors | 11.1% |
| 135 | Sarcoma, Myeloid | 11.1% |
| 136 | Carcinoma, Basal Cell | 11.1% |
| 137 | Carcinoid Tumor | 11% |
| 138 | Endometrial Neoplasms | 11% |
| 139 | Neurilemmoma | 11% |
| 140 | Hutchinson's Melanotic Freckle | 11% |
| 141 | Melanoma, Amelanotic | 11% |
| 142 | Sarcoma, Experimental | 11% |
| 143 | Prolactinoma | 11% |
| 144 | Growth Hormone-Secreting Pituitary Adenoma | 11% |
| 145 | Neoplasms, Radiation-Induced | 10.8% |
| 146 | Astrocytoma | 10.6% |
| 147 | Ependymoma | 10.6% |
| 148 | oligodendroglioma | 10.6% |
| 149 | Ganglioglioma | 10.6% |
| 150 | gliosarcoma | 10.6% |
| 151 | Anaplastic astrocytoma | 10.6% |
| 152 | Anaplastic Oligodendroglioma | 10.6% |
| 153 | Cystadenocarcinoma | 10.5% |
| 154 | Fibrosarcoma | 10.5% |
| 155 | Osteosarcoma | 10.5% |
| 156 | Mucoepidermoid Carcinoma | 10.5% |
| 157 | Pharyngeal Neoplasms | 10.5% |
| 158 | Brain Stem Neoplasms | 10.4% |
| 159 | Adenoma | 10.3% |
| 160 | Ameloblastoma | 10.3% |
| 161 | Angiokeratoma | 10.3% |
| 162 | Carcinoma | 10.3% |
| 163 | Chordoma | 10.3% |
| 164 | Hemangioma | 10.3% |
| 165 | hemangiopericytoma | 10.3% |
| 166 | Lymphangioma | 10.3% |
| 167 | Malignant Carcinoid Syndrome | 10.3% |
| 168 | Mesenchymoma | 10.3% |
| 169 | Nevus | 10.3% |
| 170 | Teratoma | 10.3% |
| 171 | Hepatoblastoma | 10.3% |
| 172 | Mixed Tumor, Mullerian | 10.3% |
| 173 | Germinoma | 10.3% |
| 174 | Teratocarcinoma | 10.3% |
| 175 | Angiofibroma | 10.3% |
| 176 | Sarcoma | 10.3% |
| 177 | Epithelioma | 10.3% |
| 178 | Choriocarcinoma | 10.2% |
| 179 | Central Nervous System Cysts | 10.2% |
| 180 | Adenofibroma | 10.2% |
| 181 | Fibroadenoma | 10.2% |
| 182 | Malignant Fibrous Histiocytoma | 10.2% |
| 183 | Lambert-Eaton Myasthenic Syndrome | 10.1% |
| 184 | Glioblastoma | 10.1% |
| 185 | Neuroblastoma | 10.1% |
| 186 | Glioblastoma Multiforme | 10.1% |
| 187 | Nephroblastoma | 10.1% |
| 188 | ovarian neoplasm | 10.1% |
| 189 | Bile Duct Neoplasms | 10.1% |
| 190 | gallbladder neoplasm | 10.1% |
| 191 | Intestinal Neoplasms | 10.1% |
| 192 | Penile Neoplasms | 10.1% |
| 193 | Prostatic Neoplasms | 10.1% |
| 194 | Stomach Neoplasms | 10.1% |
| 195 | Choroid Plexus Papilloma | 10% |
| 196 | Ganglioneuroblastoma | 9.9% |
| 197 | Bowen's Disease | 9.9% |
| 198 | Paraganglioma | 9.9% |
| 199 | Rhabdomyosarcoma | 9.9% |
| 200 | Giant Cell Tumor of Bone | 9.9% |
| 201 | Polycythemia Vera | 9.9% |
| 202 | Adrenocortical carcinoma | 9.8% |
| 203 | Leukemia, Radiation-Induced | 9.7% |
| 204 | Dermatofibrosarcoma | 9.6% |
| 205 | Dermatofibrosarcoma Protuberans | 9.6% |
| 206 | Leukoplakia | 9.5% |
| 207 | Lymphocele | 9.5% |
| 208 | Pancreatic Cyst | 9.5% |
| 209 | granulosa cell tumor | 9.3% |
| 210 | Carcinoma, Ovarian Epithelial | 9.3% |
| 211 | Barrett Esophagus | 9.3% |
| 212 | Breast Cyst | 9.3% |
| 213 | Histiocytic Disorders, Malignant | 9.3% |
| 214 | Actinic keratosis | 9.3% |
| 215 | Mediastinal Cyst | 9.3% |
| 216 | Neoplasm Invasiveness | 9.3% |
| 217 | Neoplasm Metastasis | 9.3% |
| 218 | Neoplasm Recurrence, Local | 9.3% |
| 219 | Parovarian Cyst | 9.3% |
| 220 | Pericardial Cyst | 9.3% |
| 221 | Thymic Cyst | 9.3% |
| 222 | Carcinogenesis | 9.3% |
| 223 | Myxoid cyst | 9.3% |
| 224 | Metastasis | 9.3% |
| 225 | Pheochromocytoma | 9.3% |
| 226 | Alveolar rhabdomyosarcoma | 9.3% |
| 227 | Leukemia, Plasma Cell | 9.2% |
| 228 | Mesoblastic Nephroma | 9.1% |
| 229 | Hypopharyngeal Neoplasms | 9% |
| 230 | Hypopharyngeal Cancer | 9% |
| 231 | Parotid Neoplasms | 8.9% |
| 232 | Prostatic Neoplasms, Castration-Resistant | 8.9% |
| 233 | Opsoclonus-Myoclonus Syndrome | 8.8% |
| 234 | Nelson Syndrome | 8.8% |
| 235 | Laryngeal neoplasm | 8.8% |
| 236 | Adenocarcinoma | 8.5% |
| 237 | Carcinoma in Situ | 8.5% |
| 238 | Carcinoma, Transitional Cell | 8.5% |
| 239 | Phyllodes Tumor | 8.5% |
| 240 | Dysgerminoma | 8.5% |
| 241 | Hemangioendothelioma | 8.5% |
| 242 | Lipoma | 8.5% |
| 243 | Myoma | 8.5% |
| 244 | Myxoma | 8.5% |
| 245 | Neuroma | 8.5% |
| 246 | Papilloma | 8.5% |
| 247 | Pseudomyxoma Peritonei | 8.5% |
| 248 | Seminoma | 8.5% |
| 249 | Papillomatosis | 8.5% |
| 250 | Angiolipoma | 8.5% |
| 251 | Myelolipoma | 8.5% |
| 252 | Neoplasms, Bone Tissue | 8.5% |
| 253 | Neoplasms, Fibrous Tissue | 8.5% |
| 254 | Smooth Muscle Tumor | 8.5% |
| 255 | Adenomatosis, Pulmonary | 8.5% |
| 256 | Adenomatous Polyps | 8.5% |
| 257 | Carcinoma, Large Cell | 8.5% |
| 258 | Carcinoma, Small Cell | 8.5% |
| 259 | Desmoplastic Small Round Cell Tumor | 8.5% |
| 260 | Chondroma | 8.5% |
| 261 | Enchondroma | 8.5% |
| 262 | Tonsillar Neoplasms | 8.3% |
| 263 | Renal Cell Carcinoma | 8.3% |
| 264 | Papillary Renal Cell Carcinoma | 8.3% |
| 265 | Cerebellar Neoplasms | 8.3% |
| 266 | Bladder Neoplasm | 8.3% |
| 267 | Kidney Neoplasm | 8.3% |
| 268 | Ureteral Neoplasms | 8.3% |
| 269 | Urethral Neoplasms | 8.3% |
| 270 | Lymphomatoid Granulomatosis | 8.3% |
| 271 | Adenomatous Polyposis Coli | 8.2% |
| 272 | Tuberous Sclerosis | 8.2% |
| 273 | Carcinoid Heart Disease | 8.2% |
| 274 | Composite Lymphoma | 8% |
| 275 | Carcinoma, Endometrioid | 7.9% |
| 276 | Hydatidiform Mole | 7.8% |
| 277 | Myelitis, Transverse | 7.7% |
| 278 | Adenoid Cystic Carcinoma | 7.6% |
| 279 | fibroma | 7.6% |
| 280 | Fibromatosis | 7.6% |
| 281 | Osteoblastoma | 7.6% |
| 282 | Osteoma | 7.6% |
| 283 | Rhabdomyoma | 7.6% |
| 284 | Chondromatosis | 7.6% |
| 285 | Adenocarcinoma, Clear Cell | 7.6% |
| 286 | Cholangiocarcinoma | 7.6% |
| 287 | Cervical Intraepithelial Neoplasia | 7.6% |
| 288 | Hemangioblastoma | 7.6% |
| 289 | Lymphoma, Extranodal NK-T-Cell | 7.6% |
| 290 | Cecal Neoplasms | 7.4% |
| 291 | Duodenal Neoplasms | 7.4% |
| 292 | Nasopharyngeal carcinoma | 7.2% |
| 293 | Neurofibrosarcoma | 7.1% |
| 294 | Fibromatosis, Aggressive | 7.1% |
| 295 | Fibromatosis, Abdominal | 7.1% |
| 296 | Klatskin Tumor | 7.1% |
| 297 | Basal Cell Nevus Syndrome | 7.1% |
| 298 | Lymphoma | 6.9% |
| 299 | Appendiceal Neoplasms | 6.9% |
| 300 | Colonic Neoplasms | 6.9% |
| 301 | Rectal Neoplasms | 6.9% |
| 302 | Endometrial Stromal Sarcoma | 6.9% |
| 303 | Pancreatic Pseudocyst | 6.8% |
| 304 | Plasmacytoma | 6.8% |
| 305 | Corpus Luteum Cyst | 6.8% |
| 306 | Ovarian Cysts | 6.8% |
| 307 | Malignant histiocytosis | 6.7% |
| 308 | Lymphatic Metastasis | 6.7% |
| 309 | Neoplasms, Unknown Primary | 6.7% |
| 310 | Leukemic Infiltration | 6.7% |
| 311 | Histiocytic sarcoma | 6.7% |
| 312 | Neoplasm Micrometastasis | 6.7% |
| 313 | Lymphangioleiomyomatosis | 6.6% |
| 314 | Nasopharyngeal Neoplasms | 6.4% |
| 315 | Colorectal Neoplasms | 6.3% |
| 316 | Denys-Drash Syndrome | 5.9% |
| 317 | Anus Neoplasms | 5.7% |
| 318 | Sigmoid Neoplasms | 5.7% |
| 319 | Paranasal Sinus Neoplasms | 5.6% |
| 320 | Choledochal Cyst | 5.6% |
| 321 | Leukemia, Myelomonocytic, Chronic | 5.6% |
| 322 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 5.6% |
| 323 | Peutz-Jeghers Syndrome | 5.4% |
| 324 | Maxillary Sinus Neoplasms | 5.2% |
| 325 | Thymoma | 5% |
| 326 | Mastocytoma | 5% |
| 327 | Hodgkin Disease | 5% |
| 328 | Lymphoma, Non-Hodgkin | 5% |
| 329 | Mastocytosis, Systemic | 5% |
| 330 | Polycystic Ovary Syndrome | 5% |
| 331 | Leukemia, Myeloid, Chronic-Phase | 4.9% |
| 332 | Mastocytosis | 4.3% |
| 333 | Sturge-Weber Syndrome | 4.3% |
| 334 | Cell Transformation, Viral | 4.2% |
| 335 | Gastrointestinal Stromal Tumors | 4.2% |
| 336 | Hemangioma, Cavernous | 4.2% |
| 337 | Leukemia, T-Cell | 4.1% |
| 338 | Leukemia, B-Cell | 4.1% |
| 339 | neurofibroma | 4.1% |
| 340 | Lymphoma, Follicular | 4.1% |
| 341 | T-Cell Lymphoma | 4.1% |
| 342 | Mantle cell lymphoma | 4.1% |
| 343 | Primary amyloidosis | 4% |
| 344 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.7% |
| 345 | Leukemia, Large Granular Lymphocytic | 3.7% |
| 346 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.7% |
| 347 | Lymphoma, T-Cell, Cutaneous | 3.7% |
| 348 | Lymphoma, AIDS-Related | 3.7% |
| 349 | Enteropathy-Associated T-Cell Lymphoma | 3.7% |
| 350 | Primary Effusion Lymphoma | 3.7% |
| 351 | Dupuytren Contracture | 3.6% |
| 352 | Urticaria Pigmentosa | 3.5% |
| 353 | Mycosis Fungoides | 3.4% |
| 354 | Lymphomatoid Papulosis | 3.4% |
| 355 | Plasmablastic lymphoma | 3.4% |
| 356 | Xeroderma Pigmentosum | 3% |
| 357 | Waldenstrom Macroglobulinemia | 2.9% |
| 358 | Multiple Myeloma | 2.9% |
| 359 | Zollinger-Ellison syndrome | 2.5% |
| 360 | Burkitt Lymphoma | 2.4% |
| 361 | Sezary Syndrome | 2.3% |
| 362 | Radicular Cyst | 2.3% |